#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangioma Vulval cancer recurrent Dermatomyositis Arterial tortuosity syndrome Biliary cancer metastatic Glomerulonephritis chronic B-cell lymphoma refractory Primary immunodeficiency syndrome Candida infection Squamous cell carcinoma of the hypopharynx Bronchiectasis Retinoblastoma Neoplasm malignant Fibrodysplasia ossificans progressiva Neuroendocrine cell hyperplasia of infancy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Life with Disease Leukoencephalopathy – Basic Information Methylmalonic acidaemia – Life with Disease Wolfram syndrome – Treatment Angiosarcoma non-metastatic – Basic Information Hepatic angiosarcoma – Treatment Progressive multifocal leukoencephalopathy – Basic Information Prader-Willi syndrome Angiosarcoma metastatic – Life with Disease Osteosarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meldonium TUVATEXIB Aluminium Oxide Diphenhydramine Hydrochloride Raltegravir Buserelin Acetate DUVELISIB Cefepime Hydrochloride Sar441566 Mavorixafor Iclepertin Paracetamol Nitrogen EGANELISIB Eftilagimod Alfa VANADIUM OXIDE SULFATE Ranibizumab Tovorafenib Vh4524184 Brexucabtagene Autoleucel More therapies…

    Learn about Your Condition

    Athetosis Arteriospasm coronary Genital herpes simplex Cardiac arrest Progressive multiple sclerosis Small intestine carcinoma Anal cancer stage III Acute respiratory failure BRAF gene mutation Food allergy Pleural mesothelioma Intestinal obstruction Tumour thrombosis Bile duct cancer Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Ivonescimab to FOLFOX Drug Combination for Patients with Advanced Biliary Tract Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Ivonescimab
    • Calcium Folinate
    France
  • Study on the Effectiveness of Choline Alfoscerate for Treating Mild Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • CHOLINE ALFOSCERATE
    Italy
  • Study on Avelumab and Cetuximab for Patients with Metastatic Colorectal Cancer Who Have Previously Received Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    Italy
  • Study on the Effectiveness and Safety of Budesonide and Prednisone for Children with Primary IgA Nephropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Budesonide
    • Prednisone
    Poland
  • Study on Methylphenidate for Reducing Fatigue in Childhood Brain Tumor Survivors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cancer fatigue
    Investigated Drugs:
    • METHYLPHENIDATE
    • Placebo
    Denmark
  • Exploring Precision Dosing of Infliximab for Patients with Steroid-Resistant Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    Belgium
Previous Page
1 … 287 288 289 290 291 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!